Lisa Lackey, APRN
Family · Albuquerque, NMNPI 1104122647
Payments from drug & device makers
Across 29 payments — averaging $23.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$162
- Sanofi Pasteur Inc.$114
- Novo Nordisk$101
- Lundbeck LLC$64
- GSK$55
- Lilly USA, LLC$51
- plus $143 from 7 others
What the payments were for
- Food & beverage$690100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 3 | $162 |
| Sanofi Pasteur Inc. | 4 | $114 |
| Novo Nordisk | 6 | $101 |
| Lundbeck LLC | 3 | $64 |
| GSK | 3 | $55 |
| Lilly USA, LLC | 3 | $51 |
| Vertex | 1 | $28 |
| Astellas Pharma US Inc | 1 | $26 |
| Boston Scientific | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Exact Sciences | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| AstraZeneca | 1 | $15 |
How this compares
$690 in reported general payments places this provider in the 70th percentile of 1,080 family providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 11 | $10,993 |
| SynthroidLevothyroxine Sodium | 13 | $1,497 |
| Atorvastatin Calcium | 119 | $1,175 |
| Amlodipine Besylate | 99 | $715 |
| Levothyroxine Sodium | 63 | $700 |
| Omeprazole | 40 | $478 |
| Hydroxyzine Hcl | 23 | $474 |
| Metformin Hcl | 65 | $468 |
| Losartan Potassium | 69 | $457 |
| Metoprolol Succinate | 22 | $456 |
| Rosuvastatin Calcium | 41 | $436 |
| Fluticasone Propionate | 15 | $412 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 28 | $366 |
| Ibuprofen | 30 | $335 |
| Tamsulosin Hcl | 16 | $314 |
Paid to pharmacies, not to this prescriber.
Other family in Albuquerque
- Barbara FranklinAlbuquerque$28K
- Melanie DuranAlbuquerque$15K
- Irasema LlewellynAlbuquerque$14K
- Charles GallegosAlbuquerque$10K
- Marlyn NewbyAlbuquerque$9K
- Annmarie FoleyAlbuquerque$8K
- Aimee CasarezAlbuquerque$7K
- Rita SuharliAlbuquerque$6K
- Matthew TotterAlbuquerque$6K
- Roberta ChampouillonAlbuquerque$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.